00:00
This is an incredible group of drugs, thrombolytics.
00:04
Lytic means, right blow it up, thrombus means clot.
00:08
So, these are some bad yet really good drugs.
00:12
Alteplase is another one, we call it TPA.
00:15
We use these as an emergency treatment to dissolve diagnosed
clots.
00:20
So, if the patients rolls in the ER, they're having an MI,
we've got them in the cath lab.
00:24
We know they've got a clot. This is a drug, an example of
one of them that we can use.
00:30
We don’t use this for prevention. You don’t go home on
thrombolytics.
00:34
This is an acute treatment for someone that we know has a
clot.
00:38
Usually used in the heart, also can be used for clots in the
brain,
because tPA converts plasminogen to plasmin, and plasmin is
that enzyme that dissolves clots.
00:50
Remember, it dissolves the fibrin matrix of blood clots. So,
just stop for a minute.
00:55
One of the most dramatic stories I remember with this is I
was in California.
00:59
And we had a young mother come in, who's a single mother of
children.
01:03
She had a left-sided stroke. She was completely paralyzed on
the left side of her body.
01:07
She appropriately received a thrombolytic, and walked out of
that hospital without any residual.
01:14
It gives me goosebumps just thinking about it. So, when this
drug works, it’s a miracle.
01:21
But I also remember a patient that I will never forget who
was the sole breadwinner for a very large extended family.
01:29
He came in with an MI, we ran all the screenings, did
everything that we could and he had a completely different
result.
01:37
He ended up with a major bleed in his head and did not
survive that hospital stay.
01:42
I won’t ever forget the sounds of that family as they
grieved the passing of this patriarch of their family.
01:49
So, when these drugs worked, they’re a miracle, but they
come at a very high risk.
01:56
So, you wanna be very careful when you’re a part of the
health care team
and you helped asses this patient for the risk factors.
02:03
So, let’s talk about some of those special precautions.
02:06
Even when you follow this list, to the letter, your patient
is still at risk.
02:11
There is a significant risk for life-threatening bleeding
because it dissolves all of the clots.
02:18
He clearly had something in his head that was supposed to be
there
and when we get in thrombolytic treatment, it burst open.
02:25
So, intracranial bleeding, that’s usually the biggest risk.
02:30
So, you wanna screen your patients very, very carefully
before you give them a thrombolytic.
02:35
If they have a platelet disorder, coagulopathy disorders or
history of stroke, recent surgery.
02:41
Remember, ask yourself why.
02:43
Why would it be difficult or wrong or unsafe to get a med
that lysis every clot if you have a platelet disorder?
If already of clotting problems, a thrombolytic is just
gonna intensify those.
02:57
Same thing with coagulopathy, you have a history of a stroke
that puts you on an increased risk for maybe developing a head
bleed.
03:06
So, all these factors need to be evaluated by an expert
health care team
before your patient can receive this medication at the
safest level possible.
03:16
Now, we want you to get any medication early on, on the
process
but there's a special note here about thrombolytics.
03:22
Underlying onset of symptoms. See, here’s the deal.
03:27
There’s a really tight window and most places are at 4 hours
maybe even up to 6.
03:32
Earlier is better, but at least within a 4.5 hour window of
when the patient experience the symptoms.
03:41
If it’s after that 4.5 hour window, there’s no reason to
take the risk of a thrombolytic for tissue that,
even if we reperfuse it, likely is not gonna be come back to
be viable.
03:54
Why would that be? Well, we're not trying to be difficult,
but because this is a high-risk drug.
03:58
Remember, we have some really serious outcomes with this.
04:02
It’s a high-risk drug, you wanna make sure that the tissue
on the other end of that clot is still viable.
04:08
We can get it into it in that 4-hour window.
04:11
Then we have a chance of restoring blood flow tissue that
can regenerate itself.
04:16
If it’s after that 6-hour window, there’s no reason to take
the risk of a thrombolytic
for tissue that likely even if we reperfuse it, it’s not
gonna be come back and be viable.
04:27
So, watch your patient very closely, who receives a
thrombolytic for any signs of bleeding, keep them safe,
don’t let them fall, don’t let them get up without you,
minimize any risk for tissue trauma.
04:40
So, you want their bed rails up, you wanna watch them
closely.
04:43
Sometimes, we would be even put pads on the bed rails so
they wouldn’t bump an elbow or an arm on the bed.
04:49
This patient's gonna need extended time to stop bleeding
after simple things, like a finger stick blood sugar or a
lab.
04:57
Just plan time on your care, that you’re gonna have to hold
pressure on that little tiny wound for a long period of
time.